| Size | Price | Stock | Qty |
|---|---|---|---|
| 25g |
|
||
| Other Sizes |
| Targets |
1H-Imidazole-2-carbaldehyde has been identified as a novel protein tyrosine phosphatase 1B (PTP1B) inhibitor with an important application to treat type-2 diabetes. PTP1B is a key regulator of insulin signaling, and its inhibition is a validated target for the treatment of type 2 diabetes and obesity.
|
|---|---|
| ln Vitro |
A new protein tyrosine phosphatase 1B (PTP1B) inhibitor called imidazole-2-carboxaldehyde has significant uses in preventing type 2 diabetes. The amino acids β-alanine and 2-aminobenzoic acid are used to create a condensation process that yields ligands with tridentate Schiff base carboxylates. Additionally, it has been engaged in the allylation of aldimines guided by imidazoles.
In vitro, 1H-imidazole-2-carbaldehyde serves as a crucial intermediate in the synthesis of several pharmaceuticals. Its derivatives have been investigated for their potential in developing anti-inflammatory and anti-cancer agents. As an aldehyde-containing imidazole, it is a valuable building block for the synthesis of various bioactive compounds. |
| ln Vivo |
In vivo activity data for 1H-imidazole-2-carbaldehyde as a therapeutic agent are not extensively documented. As a PTP1B inhibitor, it may have potential for the treatment of type 2 diabetes, but specific in vivo efficacy studies are not well-documented in the public literature.
|
| Enzyme Assay |
For in vitro enzyme inhibition assays, 1H-imidazole-2-carbaldehyde can be evaluated for PTP1B inhibitory activity. Standard protocols involve incubating the compound with recombinant PTP1B enzyme and measuring enzyme activity using a chromogenic or fluorogenic substrate. IC₅₀ values are calculated from dose-response curves to quantify inhibitory potency.
|
| Cell Assay |
For in vitro cell-based experiments, 1H-imidazole-2-carbaldehyde is used as an intermediate in the synthesis of compounds that are tested in cell viability, proliferation, and cytotoxicity assays. The compound itself may be evaluated for its effects on insulin signaling in cell-based assays. Standard cell culture protocols involve dissolving the compound in DMSO and diluting to working concentrations.
|
| Animal Protocol |
In vivo animal studies using 1H-imidazole-2-carbaldehyde are conducted on the final drug compounds synthesized from it, not on the intermediate itself. For potential anti-inflammatory or anti-cancer agents derived from this building block, efficacy studies would typically be performed in mouse models of the relevant disease.
|
| ADME/Pharmacokinetics |
Pharmacokinetic properties of 1H-imidazole-2-carbaldehyde as a standalone compound are not characterized in the literature. The compound has a boiling point of 296.5±23.0 °C at 760 mmHg and a density of 1.3±0.1 g/cm³.
|
| Toxicity/Toxicokinetics |
1H-Imidazole-2-carbaldehyde is a research chemical and should be handled with appropriate laboratory safety precautions. As an aldehyde, it may cause skin and eye irritation. The compound is for research use only and not for human therapeutic or diagnostic applications.
|
| Additional Infomation |
1H-Imidazole-2-carbaldehyde (2-Formylimidazole, CAS 10111-08-7) is primarily a research-grade chemical intermediate, not an FDA-approved pharmaceutical drug. Its primary applications are as a PTP1B inhibitor for diabetes research and as a crucial intermediate in the synthesis of anti-inflammatory and anti-cancer agents.
|
| Molecular Formula |
C4H4N2O
|
|---|---|
| Molecular Weight |
96.09
|
| Exact Mass |
96.032
|
| CAS # |
10111-08-7
|
| PubChem CID |
24955
|
| Appearance |
Light yellow to yellow solid powder
|
| Density |
1.3±0.1 g/cm3
|
| Boiling Point |
296.5±23.0 °C at 760 mmHg
|
| Melting Point |
209 °C (dec.)(lit.)
|
| Flash Point |
137.5±29.0 °C
|
| Vapour Pressure |
0.0±0.6 mmHg at 25°C
|
| Index of Refraction |
1.620
|
| LogP |
-0.33
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
7
|
| Complexity |
74.1
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
C1=CN=C(N1)C=O
|
| InChi Key |
XYHKNCXZYYTLRG-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C4H4N2O/c7-3-4-5-1-2-6-4/h1-3H,(H,5,6)
|
| Chemical Name |
1H-imidazole-2-carbaldehyde
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: 25 mg/mL (260.17 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (26.02 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (26.02 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 10.4069 mL | 52.0346 mL | 104.0691 mL | |
| 5 mM | 2.0814 mL | 10.4069 mL | 20.8138 mL | |
| 10 mM | 1.0407 mL | 5.2035 mL | 10.4069 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
